Jones Financial Companies
TRIB

Jones Financial Companies’s Trinity Biotech TRIB Stock Holding History

Jones Financial Companies’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29K Hold
127
– – ﹤0.01% 4112
2025
Q4 		$3.01K Buy
127
+11
+9% +$324 ﹤0.01% 3698
2025
Q3 		$3.71K Hold
116
– – ﹤0.01% 3480
2025
Q2 		$2.26K Buy
116
+100
+625% +$2.01K ﹤0.01% 3428
2025
Q1 		$300 Hold
16
– – ﹤0.01% 3561
2024
Q4 		$412 Hold
16
– – ﹤0.01% 3252
2024
Q3 		$510 Buy
16
+6
+60% +$406 ﹤0.01% 2890
2024
Q2 		$656 Buy
+10
New +$582 ﹤0.01% 2321

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jones Financial Companies's TRIB Position: Q1 2026 in Review

Jones Financial Companies held its Trinity Biotech (TRIB) position steady in Q1 2026 at 127 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #4112.

Jones Financial Companies first reported a position in TRIB in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.71K in Q3 2025. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Jones Financial Companies held 127 shares of Trinity Biotech worth $2.29K as of Q1 2026.
  • Jones Financial Companies left its Trinity Biotech share count unchanged in Q1 2026.
  • Trinity Biotech made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4112 holding.
  • Jones Financial Companies first reported a position in Trinity Biotech in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Trinity Biotech position peaked at $3.71K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.